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A new series of ethyl 6-methyl-4-(substituted)phenyl-2-(substituted)-phenacyl-thio-1,4-dihydropyrimidine-5-carboxylate (2a-x) was prepared by reaction of ethyl 1,2,3,4-tetrahydro-6-methyl-4-(substituted)phenyl-2-thioxopyrimidine-5-carboxy-late

INTRODUCTION
Bacterial infections are increasingly complicated by the ability to develop resistance to antimicrobial agents. Bacteria may be intrinsically resistant to ≥1 class of antimicrobial agents or may acquire resistance by de novo mutation or via the acquisition of resistant genes from other organisms. 1 The antimicrobial resistance is a global problem, probably due to the indiscriminate and irrational use of antibiotics, prescriptions for incorrect medicines or incorrect determinations of dose, route and/or duration. Another consideration is the uncertainty of patients receiving antibiotics about whether the quality of a generic medicine is equal to, greater than or less than its equivalent brand-name drug. The antimicrobial agent must be evaluated in-vitro and in-vivo in order to confirm their suitability for therapeutic use. 2 Recently much interest has been focused on the chemistry of 2-thioxotetrahydropyrimidine-5-carboxylate and their derivatives, known as Bigenelli compounds, owing to their diverse range of biological properties such as antimicrobial, [3] [4] [5] [6] antitumor, [5] [6] [7] [8] anti-inflammatory and/or analgesic, 9&10 antioxidant, 11 calcium channel blocker [12] [13] [14] [15] activities. Motivated by the above documents, we tried to prepare the new derivatives of ethyl 6-methyl-4-(substituted)-phenyl-2-(substituted)-phenacylthio-1,4-dihydropyrimidine-5-carboxylate (2a-x), aiming at the development of new antimicrobial agents. 
EXPERIMENTAL
Melting points were determined on an electrothermal melting point apparatus (Stuart Scientific, Model SMP1, UK) and were uncorrected. TLC was carried out using silica gel 60 F 254 precoated sheets (E. Merk, Darmstadt, Germany) and was visualized by UV lamp (Spectroline Model CM 10, USA), and/or iodine stains.
IR spectra (KBr discs) were recorded on a Shimadzu IR-470 spectrometer (Shimadzu, Japan). 1 H-NMR spectra were scanned on a Varian EM-360 L NMR spectrometer (60 MHz), (Varian, USA). Chemical shifts are expressed in δ values (ppm) relative to tetramethylsilane (TMS) as an internal standard, using DMSO-d 6 as a solvent. Elemental analyses were performed at the Micro Analytical Center, Cairo University, Cairo, Egypt. Mass spectra were recorded on a JEOL JMS 600 mass spectrometer (JEOL, Japan) at the Micro Analytical Center, Faculty of Science, Cairo University, Cairo and Central Lab., Assiut University, Assiut, Egypt.
Most A mixture of ethyl 6-methyl-4-(substitutedphenyl)-2-thioxo-1,4dihydro-pyrimidine-5-carboxylate (1a-d) (1.0 mmol), appropriate phenacyl bromide (1.1 mmol) in anhydrous acetone (25 ml) was refluxed for 30 min, the formed precipitate was filtered, dried and crystallized from ethanol (Scheme 1, Table I) . : 3420 (NH stretching), 1707 (carbonyl group of the ester), 1648 (carbonyl group of phenacyl moiety) and 1512 (C=N stretching vibration). 
Ethyl 6-methyl-4-(4-bromophenyl)-2-(4-nitrophenacylthio)-1,4-dihydropyrimidine-
Materials and methods
2&16
To prepare inocula for bioassay, bacterial strains were individually cultured for 24 hrs in 100 ml conical flasks containing 30 ml nutrient broth medium. Bioassay was done in 10 cm sterile plastic Petri plates in which bacterial suspension (1 m/plate) and 15 ml Nutrient agar medium (15 ml/plate) were poured. After solidification of the media, 5 mm diameter cavities were cut in the solidified agar (4 cavities/plate) using sterile cork borer. Tested compounds dissolved in dimethyl sulfoxide (DMSO) at 100 µmol/ml were pipetted in the cavities (20 µl/cavity). Cultures were then incubated at 28°C for 48 hrs. Results were read as the diameter (in mm) of inhibition zone around cavities.
Antifungal activity Organisms
Six pathogenic, phytogenic, or foodpoisning fungal species were used in the present study: Candida albicans (AUMC No. 
Materials and method
2&16
To prepare inocula for bioassay, Fungi were grown for 7 days in 100 ml conical flasks containing 30 ml sabouraud`s dextrose broth. Bioassay was done in 10 cm sterile plastic Petri plates in which fungal suspension (1 m/plate) and 15 ml sabouraud`s dextrose agar medium (15 ml/plate) were poured. After solidification of the media, 5 mm diameter cavities were cut in the solidified agar (4 cavities/plate) using sterile cork borer. Tested compounds dissolved in dimethyl sulfoxide (DMSO) at 100 µmol/ml were pipetted in the cavities (20 µl/cavity). Cultures were then incubated at 28°C up to 7 days. Results were read as the diameter (in mm) of inhibition zone around cavities.
For determination of the minimum inhibitory concentrations (MICs), tested compounds giving positive results were diluted with DMSO to prepare a series of descending concentrations down to 0.39 µmol/ml. diluted compounds were similarly assayed as mentioned before and the least concentration (below which no activity) was recorded as the MIC.
RESULTS AND DISCUSSION
Chemistry
Ethyl 6-methyl-4-(substituted)phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates (1a-d) were synthesized according to a reported procedure through reaction of the appropriate aldehyde with thiourea and ethylacetoacetate [17] [18] [19] . S-alkylation of compounds (1a-d) with phenacyl bromides in dry acetone afforded compounds (2a-x) as their hydrobromide salts in an excellent yields (85-93%). It was reported that, S-alkylation supercsedes the N-alkylation due to the difference in nucleophilicity between sulfur and nitrogen atoms 7&8 . Structures of compounds (1a-d) were confirmed by comparison with the reported data [17] [18] [19] 
Antimicrobial activities Antibacterial activity
The newly synthesized compounds (2a- The test compounds (2a-x) were assayed using the standard agar cup diffusion method 16 at a concentration of 100 µmol/mL and those giving positive results were diluted with DMSO to prepare a series of descending concentrations down to 0.39 µmol/mL and were similarly assayed and the test concentration (below which no activity) was recorded as the MIC.
Results of the antibacterial activity, table II, indicated that at a concentration of 100 µmol/mL most of the test compounds were active against most of the used bacterial strains. Compounds 2a, 2s and 2v were completely inactive against all used organisms. Compounds 2b, 2m and 2w were active only against Staphylococcus aureus and compounds 2c, 2f and 2g were active only against Bacillus cereus. In addition, the active compounds (2a-x) showed 51. Again, from tables III and IV, compounds 2n, 2o and 2r have a wide spectrum of antibacterial activity being able to inhibit all test bacterial organisms with MICs ranging from 100 to 0.39 µmol/mL. Compounds 2i, 2k and 2l were effective against four out of five bacterial strains with MICs ranging from 100 up to 6.25 µmol/mL. It is noteworthy to mention that, the most active compounds comprise in their structures an electron withdrawing group (R 1 =Cl; R 2 = Br, Cl, or NO 2 ) while the least active compounds comprise in their structures an electron donating group (R 1 =H, CH 3 ; R 2 = OCH 3 , CH 3 ).
Antifungal activity
Compounds (2a-x) were tested for their in-vitro antifungal activity using the standard agar disc diffusion method against Candida albicans ( Also, the results indicated that compound 2f has a wide spectrum of antifungal activity being able to inhibit all test fungal organisms with MICs ranging from 50 to 12.5 µmol/mL. Compounds 2b and 2q were effective against four out of six fungal strains with MICs ranging from 100 to 6.25 µmol/mL. Again, it is noteworthy to mention that the most active compounds comprise in their structures an electron withdrawing group (R 1 = H, Cl; R 2 = Br, NO 2 ) while the least active compounds comprise in their structures an electron donating group (R 1 = CH 3 ; R 2 = CH 3 , OCH 3 ). Pi = partial inhibition -= no inhibition CHL= Chloramphenicol AUMC = Assiut University Mycological Center 
